CVA Family Office’s Eastman Chemical EMN Stock Holding History

CVA Family Office’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.2K	Buy	197 +139	+240%	+$10.2K	﹤0.01%	943
2026 Q1	$4.43K	Buy	58 +50	+625%	+$3.6K	﹤0.01%	1272
2025 Q4	$511	Buy	+8	New	+$493	﹤0.01%	1224
2025 Q3	–	Sell	-7	Closed	-$523	–	1316
2025 Q2	$523	Buy	7 +2	+40%	+$157	﹤0.01%	1222
2025 Q1	$441	Buy	+5	New	+$472	﹤0.01%	1342
2023 Q3	–	Sell	-175	Closed	-$14.7K	–	448
2023 Q2	$14.7K	Buy	175 +165	+1,650%	+$13.4K	﹤0.01%	670
2023 Q1	$843	Sell	10 -15	-60%	-$1.29K	﹤0.01%	914
2022 Q4	$2.04K	Buy	+25	New	+$2.01K	﹤0.01%	828
2022 Q2	–	Sell	-115	Closed	-$13K	–	927
2022 Q1	$13K	Hold	115	–	–	﹤0.01%	635
2021 Q4	$14K	Buy	+115	New	+$12.8K	﹤0.01%	583
2021 Q3	–	Sell	-115	Closed	-$13K	–	514
2021 Q2	$13K	Hold	115	–	–	﹤0.01%	601
2021 Q1	$13K	Buy	+115	New	+$12.5K	﹤0.01%	488

Other funds holding EMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

CVA Family Office's EMN Position: Q2 2026 in Review

CVA Family Office increased its Eastman Chemical (EMN) stake by 240% in Q2 2026, buying an estimated $10.2K and bringing the position to 197 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

CVA Family Office first reported a position in EMN in Q1 2021 and has held it in 12 quarters since. The position peaked at $14.7K in Q2 2023. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

CVA Family Office held 197 shares of Eastman Chemical worth $13.2K as of Q2 2026.
CVA Family Office bought 139 Eastman Chemical shares in Q2 2026, an estimated $10.2K.
Eastman Chemical made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #943 holding.
CVA Family Office first reported a position in Eastman Chemical in Q1 2021 and has held it in 12 quarters since.
CVA Family Office's Eastman Chemical position peaked at $14.7K in Q2 2023.
642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.